China Digest: CWBIO raises $36m; Regent Pacific acquires DLI

Chinese biology reagents developer CWBIO has raised 245 million yuan ($36 million) led by venture capital firm Addor Capital while Hong Kong-based Regent Pacific has agreed to acquire all shares in DLI for about HK$29.56 million ($4 million).